NANOG and nonpapillary renal cell carcinoma: In Kaplan-Meier survival analysis, ccRCC patients, whose tumors expressed higher nuclear levels of OCT4 and NANOG, showed significantly poorer PFS than other phenotypes expressions (P = 0.040).